Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 396

PDF Downloaded: 187


Get Permission Nerkar and Pawale: An evaluation of the 2019 novel coronavirus (COVID-19) disease


Introduction

The city of Hubei Province of China transmitted the virus to the other parts of the world, and almost all parts of the world were affected in 2019 by novel coronavirus (2019-nCoV) or the intense acute respiration syndrome corona virus 2 (SARS-CoV-2).1, 2 Coronavirus is one of the important pathogens that mostly goal the human respiratory system. Previous outbreaks of corona viruses (CoVs) consist of the intense acute respiration syndrome (SARS)-CoV and the Middle East respiration syndrome (MERS)-CoV that have been formerly characterised as retailers which might be a first rate public fitness hazard. In past due December 2019, a cluster of sufferers became admitted to hospitals with an preliminary analysis of pneumonia of an unknown etiology. These patients have been epidemiologically having a seafood and moist animal entire sale marketplace.3, 4 SARS CoV- 2 is related to an ongoing outbreak of extraordinary pneumonia (Covid-2019). More seriously, the epidemic endured to unfold from China to Europe, North America, and different Asian nations, no matter first rate efforts and more and more humans being cured in China. On January 30, 2020, WHO declared Coronavirus as gobal emergency and in February 2020 as an epidemic.5, 6, 7 Coronavirus (CoV) is a big own circle of relatives of super-coiled single-stranded RNA viruses that belong to the Nidovirales order. The order consists of Roniviridae, Arteriviridae, and Coronaviridae families. The Coronaviridae in system of nomenclature of viruses of relatives is subdivided into Torovirinae and Coronavirinae subfamilies. Coronavirinae is similarly sub categorized into alpha-, beta-, gamma-, and delta-COVs.8 Their viral RNA genome stages from 26 to 32 kilobases in length. They may be remoted from extraordinary animal species. These consist of birds, stay stock, and mammals which include camels, bats, masked palm civets, mice, dogs, and cats.9 The extensive unfold distribution and infectivity of COV make it a crucial pathogen. The repeated emergence and outbreaks of CoVs imply a public health hazard. This indicates the opportunity of animal-to-human and human-to-human transmission of newly rising CoVs. The ongoing adjustments in ecology and weather make destiny emergence of such infections extra probably.10

Review

Origin and transmission of SARS-CoV-2

The SARS-CoV-2 is a γ -coronavirus, enveloped in non-segmented super coiled single spiral RNA, (subgenus sarbecovirus, Orthocoronavirinae subfamily).11 Coronaviruses (CoV) has 4 genera, which include α−/β−/γ−/δ-CoV.

  1. α- and β-CoV: infect mammals, while

  2. γ- and δ-CoV: contaminate birds.

Previously, six CoVs are designated as human-infective virus, amongst several has low pathogenicity, may cause moderate respiration signs such as cold and fever. The different regarded γ -CoVs, SARS-CoV and MERS-CoV cause intense and severe acute respiratory tract infections.12 Based on virus genome sequencing effects and evolutionary evaluation, bat has been suspected as herbal host of virus beginning, and SARS-CoV-2 is probably transmitted from bats thru unknown intermediate hosts to contaminate people as shown in (Figure 1).

Figure 1

Viral and host elements that have an effect on the pathogenesis of SARS-CoV-2.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/28c6a37a-2245-466d-a7eb-3959c88528c6image1.png

Structure of virions

Figure 2

Structure of the Corona virusvirion: (A) Electron micrograph of MHV debris. (B) Schematic of virion. Viral debris include an inner helical RNA-protein nucleocapsid surrounded through an envelope containing viral glycoproteins. Nucleocapsid (N) protein is a phosphoprotein this is complexed with genome RNA to shape the nucleocapsid. Spike glycoprotein (S) paperwork the big glycosylated peplomers which might be feature of corona viruses. M, the transmembrane protein, is fantastically hydrophobic and spans the membrane 3 times. E, a membrane-spanning protein, is a minor element of the membrane. Some organization II viruses specific some other glycoprotein, hemagglutinin-esterase (HE), which has a framework of smaller spikes on virions.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/28c6a37a-2245-466d-a7eb-3959c88528c6image2.png

Genome shape of corona viruses

Corona viruses encode 5 structural proteins of their genomes. These are the Spike (S), Membrane (M), Envelope (E) glycoproteins, Hemagglutinin Esterase (HE) and Nucleocapsid (N) protein, (Figure 2) All envelope proteins and N protein is found in all virions however HE is best found in a few beta corona viruses.13 In addition to that, it's miles idea the virus debris are huddled collectively because of interplay among those proteins.14, 15, 16. S Glycoproteins: S Glycoproteins are positioned out of doors the virion and deliver the virion the standard shape. The S proteins shape homotrimers, which permit the formation of sun-like morphologies that deliver the call of Corona viruses.17, 18, 19 S proteins bind to the virion membrane thru the C-terminal transmembrane areas and additionally they have interaction with M proteins.20 Virions may be certain to unique floor receptors withinside the plasma membrane of the host mobile thru the N-terminus of the S proteins.21 M Glycoproteins: M Glycoproteins have 3 transmembrane areas. M proteins are glycosylated withinside the Golgi equipment.22, 23, 24 This amendment of the M protein is important for the virion to fuse into the mobile and to make protein antigenic.25, 26, 27 The M protein performs a key position in regenerating virions withinside the mobile. N protein framework a complicated through binding to genomic RNA and M protein triggers the formation of interacting virions on this endoplasmic reticulum-Golgi equipment intermediate compartment (ERGIC) with this complicated.22, 23, 24, 25, 26, 27, 28, 29 E Glycoproteins: E Glycoproteins are small proteins which might be composed of about 76 to 109 amino acids. About 30 amino acids withinside the N-terminus of the E proteins permit attachment to the membrane of viruses.30 In addition, coronavirus E proteins play a essential position withinside the meeting and morphogenesis of virions. In one examine coronavirus E and M proteins have been expressed collectively with mammalian expression vectors to shape virus-like systems31, 32, 33 In some other examine, there has been a substantial lower withinside the cappotential of the recombinant mouse hepatitis virus (MHV) and SARS viruses to elicit E protein expression withinside the genome to aid this status.34, 35 N Proteins: N proteins are phosphoproteins which might be able to binding to helix and feature bendy shape of viral genomic RNA. It performs an crucial position in virion shape, replication and transcription of corona viruses, due to the fact the N protein localizes withinside the replication/ transcriptional vicinity of the corona viruses and the ERGIC vicinity wherein the virus is collected.28, 36

Pathogenesis of COVID-19

COVID-19 is recognized with symptoms inclusive of fever, nonproductive cough, dyspnea, myalgia, fatigue, normal or decreased leukocyte counts, and radiographic evidence of pneumonia,37 which is probably like the symptoms of SARS-CoV and MERS-CoV infections.38 Hence, even though the pathogenesis of COVID-19 is poorly understood, the identical mechanisms of SARS-CoV and MERS-CoV nevertheless can supply us lots of records on the pathogenesis of SARS-CoV-2 infection to facilitate knowledge of COVID-19.

Figure 3

Diagnosis of COVID-19.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/28c6a37a-2245-466d-a7eb-3959c88528c6image3.png

Coronavirus access and replication

Coronavirus S protein has been mentioned as a substantial determinant of virus access into host cells.39 The envelope spike glycoprotein binds to its cell receptor, ACE2 for SARS-CoV40 and SARS-CoV-2,41 CD209L (a C-kind lectin, additionally known as L-SIGN) for SARS-CoV42, DPP4 for MERS-CoV.43 The access of SARS-CoV into cells became to begin with diagnosed to be done through direct membrane fusion among the virus and plasma membrane.44 Belouzard et al.45 located that a critical proteolytic cleavage event came about at SARS-CoV S protein at position (S2') mediated the membrane fusion and viral infectivity. MERS-CoV moreover has superior unusual -step furin activation for membrane fusion.46 Besides membrane fusion, the clathrin-primarily based totally and unbiased endocytosis mediated SARS-CoV get right of entry to too.47, 48 After the virus enters the cells, the viral RNA genome is released into the cytoplasm and is translated into polyproteins and structural proteins, after which the viral genome begins off evolved to replicate.49 The newly formed envelope glycoproteins are inserted into the membrane of the endoplasmic reticulum or Golgi, and the nucleocapsid is formed thru the combination of genomic RNA and nucleocapsid protein. Then, viral particles germinate into the endoplasmic reticulum Golgi intermediate compartment (ERGIC). At last, the vesicles containing the virus particles then fuse with the plasma membrane to release the virus.39

Diagnostic techniques for COVID-19

The real-time RT-qPCR for detection of COVID-19 in nasopharyngeal and throat swabs or oropharyngeal swabs has been gold standard for detection of coronavirus disease. For the analysis of COVID-19, even though RT-qPCR is unique, its price cannot be neglected due to the intense outcomes of overlooked analysis. CT scans which in in vivo and RT-Qpcr is ex-vivo technique. Out of which RT-PCR being the sensitive, whereas the CT- Scans being auxillary shows ground glass opacities of lung involvement. Of patients inflamed with SARS-CoV-250, 51, 52, 53 According to the ones findings, CT scans have a first rate scientific diagnostic cost for COVID-19, specifically within the excessive incidence vicinity of SARS-CoV-2. However, CT scans additionally have a drawback, which include undifferentiations from different viral pneumonia and the hysteresis of unusual CT imaging. The CT imaging should be additionally accompanied with immunological test such as IgG/ Ig M detection and ELISA assay by kits. The sensitivity of SARS-CoV N-primarily based totally IgG ELISA (94.7%) is extensively better than that of SARS-CoV S-primarily based totally IgG ELISA (58.9%),54 however the sensitivity of SARS-CoV-2 IgG/IgM stays to be studied.

Symptoms

The signs of COVID-19 contamination seem after an incubation duration of about 5.2 days.55 The duration from the onset of COVID-19 signs to death ranged from 6 to 41 days with an average of 14 days. This duration is depending on the age of the affected person and standing of the affected person's immune system. It became shorter amongst sufferers >70-years vintage as compared with the ones below the age of 70.56 The maximum signs at onset of COVID-19 infection are fever, cough, and fatigue, whilst different signs consist of sputum production, headache, haemoptysis, diarrhoea, dyspnoea, and lymphopenia57, 10, 56, 58 Clinical capabilities found out through a chest CT experiment provided as pneumonia, however, there have been unusual capabilities which include anaemia, acute respiration misery syndrome, acute cardiac injury, and occurrence of grand-glass opacities that caused the death.10 In a few instances, couple of peripheral ground-glass opacities have been found in subpleural areas of each lungs that probably prompted each systemic and localized immune reaction that caused accelerated inflammation. Regrettably, remedy of a few instances with interferon inhalation confirmed no scientific impact and rather regarded to get worse the circumstance through progressing pulmonary opacities.58 It is crucial to notice that there are similarities withinside the signs among COVID-19 and in advance beta coronavirus which include fever, dry cough, dyspnea, and bilateral ground-glass opacities on chest CT scans.10 However, COVID-19 confirmed a few specific scientific capabilities that consist of the concentrated on of the decrease airway as glaring through top respiration tract signs like rhinorrhoea, sneezing, and sore throat.37, 38 In addition, primarily based totally on effects from chest radiographs upon admission, a number of the instances display an infiltrate withinside the top lobe of the lung this is related to growing dyspnea with hypoxemia.59 Importantly, wherein as affected person inflamed with COVID-19 advanced gastrointestinal signs like diarrhoea, a low percent of MERS-CoV or SARS-CoV sufferers skilled comparable GI misery. Therefore, it's miles crucial to check faecal and urine samples to exclude a ability opportunity path of transmission, in particular thru fitness care workers, sufferers etc.37, 38 Therefore, improvement of techniques to become aware of the numerous modes of transmission which include feacal and urine samples are urgently warranted for you to increase techniques to inhibit and/or limit transmission and to increase therapeutics to manipulate the disorder. Current remedy techniques for COVID-19. At present no clinical agent antiviral can be employed for the successful treatment of SARS-CoV and MERS-CoV.60 The supportive remedy together with oxygen remedy, conservation fluid control, and the usage of extensive-spectrum antibiotics to cowl secondary bacterial contamination, stays to be the maximum crucial control strategy.10 According to studies to prevent the pathogenesis of SARS-CoV-2, there are numerous molecular mechanisms available,9 thus based on these studies the repurposing of the antiviral agents may be a promising therapy for the healing and treatment of SARS-COV-2.

Potential healing techniques in opposition to COVID-19

Initially, interferons-α nebulization, extensive-spectrum antibiotics, and anti-viral pills have been used to lessen the viral load61, 62, 63 however, best remdesivir has proven promising effect in opposition to the virus.64 Remdesivir best and in mixture with chloroquine or interferon beta extensively blocked the SARS-CoV-264 replication and sufferers have been declared as clinically recovered.65, 66, 67 Various different anti-virals are presently being evaluated in opposition to contamination. Nafamostat, Nitazoxanide, Ribavirin, Penciclovir, Favipiravir, Ritonavir, AAK1, Baricitinib, and Arbidol exhibited slight effects while examined in opposition to contamination in sufferers and in-vitro scientific isolates.65, 66, 68, 67 Several different mixtures, which include combining the antiviral or antibiotics with conventional Chinese drug treatments have been additionally evaluated in opposition to SARS-CoV-2 prompted contamination in people and mice.65 Recently in Shanghai, in an experiment , blood plasma from covid recovered patients was injected in inflamed patients and shown to have advance recovery.69 In a study it was suggested and observed that monoclonal antibody (CR3022) binds with the spike RBD of SAR-CoV-2. The antibody epitope of CR3022 has the advance healing therapeutic index, on individually or in mixture with different neutralizing antibodies for the prevention and remedy of COVID-19 contamination.70

Table 1

Common and potent antiviral drugs.71

Status

Drugs

Action mode

Anti-infective mechanism

Target diseases

Approved

Lopinavir/ Ritonavir

Protease inhibitors

Inhibiting HIV-1 protease for protein cleavage, resulting in non-infectious immature viral particles

HIV-AIDS, SARS, MERS

Approved, Investigational, Vet approved

Chloroquine

9-aminoquinolin

Increasing endosomal pH, immunomodulating autophagy inhibitors

Malaria, autoimmune disease

Experimental

Remdesivir (GS-5734)

Nucleotide analogue prodrug

Interfering with virus post-entry

Ebola, SARS, MERS (A wide array of RNA viruses)

Investigational

Nafamostat

Synthetic serine protease inhibitors

Prevents membrane fusion by reducing the release of cathepsin B; anticoagulant activities

Influenza, MERS, Ebola

Approved

Ribavirin

Synthetic guanosine nucleotide

Interfering with the synthesis of viral mRNA (a broad spectrum activity against several RNA and DNA viruses)

HCV, SARS, MERS

Approved

Oseltamivir

Neuraminidase inhibitor

Inhibiting the activity of the viral neuraminidase enzyme, preventing budding from the host cell, viral replication, and infectivity

Influenza viruses A

Approved

Penciclovir/Acyclovir

Nucleoside analog

A synthetic acyclic guanine derivative, resulting in chain termination

HSV/VZV

Approved, Investigational

Ganciclovir

Nucleoside analog

Potent inhibitor of the Herpes virus family including cytomegalovirus

AIDS-associated Cytomegalovirus infections

Investigational

Favipiravir (T-705)

Nucleoside analog viral RNA polymerases inhibitors

Acting on viral genetic copying to prevent its reproduction, without affecting host cellular RNA or DNA synthesis

Ebola, Influenza A(H1N1)

Approved, Investigational, Vet approved

Nitazoxanide

Antiprotozoal agent

Modulating the survival, growth and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, viruses

A wide range of viruses including human/ animal coronavirus

[i] HIV Human immune deficiency virus, AIDS Acquired immune deficiency syndrome, SARS Severe acute respiratory syndrome, MERS Middle East respiratory syndrome, HCV Hepatitis C virus, HSV Herpes simplex virus, VZV Varicella-zoster virus

Antibody and plasma remedy

It has additionally been mentioned that there are numerous convalescent sufferers donating plasma in opposition to SARS-CoV-2, simply as SARS-CoV72 and MERS-CoV trials.73 It has initial received favourable effects in acute, intense SARS-CoV-2 sufferers. Moreover, it was demonstrated that the technology of recombinant human monoclonal antibody (mAb) is a reasonably has ability to neutralize SARS-CoV. CR3022, a SARS coronavirus-unique human monoclonal antibody, can bind potently with the receptor-binding domain (RBD) of SARS-CoV-2 and has ability to uncomplicate and treat the infections of SARS-CoV.74 Other monoclonal antibodies neutralizing SARS-CoV, for the future development of the antibody plasma remedy include m396, CR3014, which might support the prognosis in SARS-CoV-2.67

Future guidelines

Extensive measures to lessen man or woman-to-man or woman transmission of COVID-19 are required to manipulate the cutting-edge outbreak. Special interest and efforts to shield or lessen transmission must be carried out in prone populations together with children, fitness care providers, and aged humans. A guiding principle became posted for the scientific staff, healthcare providers, and, public fitness people and researchers who're interested by the 2019-nCoV.74 The early dying instances of COVID-19 outbreak passed off mostly in aged humans, probably because of a susceptible immune gadget that lets in quicker development of viral contamination.58,57] The public offerings and centers must offer decontaminating reagents for cleansing palms on a habitual basis. Physical touch with moist and infected items must be taken into consideration in coping with the virus, specifically retailers which include faecal and urine samples that may doubtlessly function an opportunity path of transmission.37, 38 China and different nations together with the United States have applied important prevention and manage measures together with journey screenings to manipulate similarly unfold of the virus.75 Epidemiological adjustments in COVID-19 contamination must be monitored taking into consideration ability routes of transmission and subclinical infections, further to the adaptation, evolution, and virus unfold amongst people and viable intermediate animals and reservoirs. Significant wide variety of questions that want to be addressed. These consist of, however aren't confined to, information about who and what number of had been examined, what percentage of those became superb and whether or not this price stays consistent or variable. Very few paediatric instances have up to now been mentioned; is that this because of loss of trying out or a real loss of contamination/susceptibility? Of those which have up to now been examined, what number of have advanced intense disorder and what number of have been examined superb however confirmed no scientific signal of disorder? There are a few primary questions that could offer a framework for which extra unique and precise public fitness measures may be applied.

Conclusions

The novel coronavirus originated from the Human seafood marketplace at Wuhan, China wherein bats, snakes, raccoon dogs, palm civets, and different animals are sold, and was transmitted to as much as 213 nations. The zoonotic supply of SARS-CoV-2 isn't showed, however, collection-primarily based totally evaluation recommended bats as the important reservoir. DNA recombination became observed to be worried at spike glycoprotein which diverse SARS-CoV (CoVZXC21 or CoVZC45) with the RBD of some other Beta CoV, as a result might be the purpose for go-species transmission and fast contamination. The researchers are running to increase green healing techniques to address the unconventional coronaviruses. Various extensive-spectrum antivirals formerly used in opposition to influenza, SARS and MERS coronaviruses had been evaluated both on individually or in mixtures to deal with COVID-19 sufferers, mice models, and scientific isolates. Remdesivir, Lopinavir, Ritonavir, and Oseltamivir extensively blocked the COVID-19 contamination in inflamed sufferers. Most importantly, human coronaviruses concentrated on vaccines and antiviral pills must be designed that might be used in opposition to the cutting-edge in addition to destiny epidemics. The symptoms and signs of SARS-CoV-2 prompted COVID-19 are alike influenza and seasonal allergies (pollen allergies). Person affected by influenza or seasonal hypersensitive reaction may show off temperature which may be detected through thermo-scanners, subsequently the man or woman becomes suspected. Therefore, an correct and fast diagnostic package or meter for detection of SARS-CoV-2 in suspected sufferers is required, because the RT-qPCR primarily based totally trying out is costly and time consuming. More so, destiny outbreaks of viruses and pathogens of zoonotic beginning are probably to continue. Therefore, aside from curtailing this outbreak, efforts must be made to plan complete measures to save outbreaks of zoonotic beginning.

Source of Funding

None.

Conflict of Interest

None.

References

1 

C Wang P W Horby F G Hayden G F Gao A novel coronavirus outbreak of global health concernLancet2020395102234703

3 

A Bogoch A Watts A T Bachli C Huber U G K Mortiz K Khan Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travelJ Trav Med202027217

4 

H Lu C W Stratton Y W Tang Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracleJ Med Virol20209244012

5 

E Callaway Time to use the p-word? Coronavirus enters dangerous new phaseNature202092947

6 

V J Munster M Koopmans N V Doremalen D V Riel E D Wit A novel coronavirus emerging in china-key questions for impact assessmentN Engl J Med202038286924

7 

WHO Coronavirus disease (COVID-19) pandemic.2020https://www.who.int/emergencies/diseases/novel-coronavirus-2019

8 

A R Fehr S Perlman Corona viruses: an overview of their replication and pathogenesisMethods Mol Biol201512821123

9 

R Lu X Zhao J Li Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingLancet202039510224302519

10 

C Huang Y Wang X Li Clinical features of patients infected with 2019 novel coronavirus in WuhanChina Lancet202039510223497506

11 

N Zhu D Zhang W Wang X Li B Yang J Song A novel coronavirus from patients with pneumonia in ChinaN Engl J Med2019382872733

12 

Y Yin R G Wunderink SARS and other coronaviruses as causes of pneumoniaRespirology20182321307

13 

A Lissenberg M M Vrolijk A V Vliet M A Langereis J D G Mijnes P Rottier Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hem agglutinin esterase protein display reduced fitness in vitroJ Virol200579241505463

14 

C A De Haan P J M Rottier Molecular interactions in the assembly of coronavirusesAdv Virus Res200564165230

15 

P S Masters The molecular biology of corona virusesAdv Virus Res200666193292

16 

R W Susan L L Julian Coronavirus pathogenesisAdv Virus Res20118185164

17 

R L Graham R S Baric Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmissionJ Virol2010847313446

18 

M Barcena G T Oostergetel W Bartelink F G A Faas A Verkleij P J M Rottier Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirionProc Natl Acad Sci U S A200910625827

19 

Y J Tan S G Lim W Hong Characterization of viral proteins encoded by the SARS-coronavirus genomeAntiviral Res20056526978

20 

S Chinese Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in ChinaJ Sci2004303566416669

21 

D N Lewicki T M Gallagher Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen- related cell adhesion molecule cellular receptorsJ Biol Chem2002277221972734

22 

C D Haan P S Masters L Kuo H Vennema P J M Rottier Coronavirus particle assembly: primary structure requirements of the membrane proteinJ Virol1998728683850

23 

K V Holmes E W Doller L S Sturman Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoproteinVirol J1981115233444

24 

H Niemann R Geyer H D Klenk D Linder S Stirm M Wirth The carbohydrates of mouse hepatitis virus (MHV) A59: structures of the O-glycosidically linked oligosaccharides of glycoprotein E1EMBO J19843366570

25 

C D Haan M D Wit L Kuo C M Morrison B L Haagmans S R Weiss The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brainJ Virol20033122395406

26 

S Alexander J H Elder Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigensJ Sci19842264680

27 

E Wissink M V Kroese M Bonsing J G Meulenberg J V Rijn P A Rijsewijk Significance of the oligosaccharides of the porcine reproductive and respiratory syndrome virus glycoproteins GP2a and GP5 for infectious virus productionJ Gen Virol20048512371523

28 

D Escors J Ortego L Enjuanes The membrane M protein of the transmissible gastroenteritis coronavirus binds to the internal core through the carboxy-terminusAdv Exp Med Biol2001753131224

29 

K Narayanan S Makino Characterization of nucleocapsid-M protein interaction in murine coronavirusAdv Exp Med Biol20017417812734

30 

M J Raamsman J K Locker A De Hooge A A De Vries G Griffiths H Vennema Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein EJ. Virol2000745233342

31 

P Baudoux C Carrat L Besnardeau B Charley H Laude Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytesJ Virol19987211863643

32 

H Vennema G J Godeke J W Rossen W F Voorhout M C Horzinek D J Opstelten Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genesEMBO J199615820208

33 

E C Bos W Luytjes H V Der Meulen H K Koerten W J Spaan The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virusJ Virol199621815260

34 

ML De Diego E Alvarez F Almazan MT Rejas E Lamirande A Roberts A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivoJ Virol2007814170113

35 

L Kuo P S Masters The small envelope protein E is not essential for murine coronavirus replicationJ Virol20037784597608

36 

S Stertz M Reichelt M Spiegel T Kuri L M Sobrido A G Sastre The intracellular sites of early replication and budding of SARS-coronavirusJ Virol2007361230415

37 

A Assiri JA Al Tawfiq A Al Rabeeah Al R Fa Al Hajjar A Al Barrak Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect Dis201313975261

38 

N Lee D Hui A Wu P Chan P Cameron G M Joynt A major outbreak of severe acute respiratory syndrome in Hong KongN Engl J Med200334820198694

39 

E De Wit N V Doremalen D Falzarano SARS and MERS: recent insights into emerging coronavirusesNat Rev Microbiol201614852334

40 

W Li M J Moore N Vasilieva Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature200342669654504

41 

F Wu S Zhao B Yu A new coronavirus associated with human respiratory disease in ChinaNature202057977982659

42 

S A Jeffers S M Tusell L Gillim-Ross CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirusProc Natl Acad Sci U S A2004101441574853

43 

V S Raj H Mou S L Smits Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCNature201349574402514

44 

G Simmons J D Reeves A J Rennekamp Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entryProc Natl Acad Sci U S A20041011242405

45 

S Belouzard V C Chu G R Whittaker Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sitesProc Natl Acad Sci U S A20091061458716

46 

J K Millet G R Whittaker Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike proteinProc Natl Acad Sci U S A201411142152149

47 

H Wang P Yang K Liu SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathwayCell Res2008182290301

48 

K Kuba Y Imai T O Nakanishi Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transportersPharmacol Ther2010128111928

49 

S Perlman J Netland Coronaviruses post-SARS: update on replication and pathogenesisNat Rev Microbiol20097643950

50 

H Shi X Han C Zheng Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in WuhanChina Radiol2020295120

51 

M Chung A Bernheim X Mei CT imaging features of 2019 novel coronavirus (2019-nCoV)Radiology20202952027

52 

G C Ooi P L Khong N L Muller Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patientsRadiol2004230383644

53 

A M Ajlan R A Ahyad L G Jamjoom Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findingsAJR Am J Roentgenol201420347827

54 

P C Y Woo S K P Lau B Wong Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumoniaJ Clin Microbiol200543730548

55 

Q Li X Guan P Wu X Wang L Zhou Y Tong Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumoniaN Engl J Med2020382131199207

56 

W Wang J Tang F Wei Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in WuhanChina J Med Virol20209244417

57 

L L Ren Y M Wang Z Q Wu Z C Xiang L Guo T Xu Identification of a novel coronavirus causing severe pneumonia in human: a descriptive studyChin Med J20201339101524

58 

W G Carlos D Cruz C S Cao B Pasnick S Jamil Novel wuhan (2019-nCoV) coronavirusAm J Respir Crit Care Med2020201478

59 

L T Phan T V Nguyen Q C Luong T V Nguyen H T Nguyen H Q Le Importation and human-to-human transmission of a novel coronavirus in VietnamN Engl J Med202038298724

60 

A Zumla J F Chan E I Azhar Coronaviruses - drug discovery and therapeutic optionsNat Rev Drug Discov201615532747

61 

C S Ng D M Kasumba T Fujita H Luo Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent cell deathCell Death Differ2020120236382

62 

B X Wang E N Fish Global virus outbreaks: Interferons as 1st respondersSemin Immunol201943101300

63 

M Wang R Cao L Zhang X Yang J Liu M Xu Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Res202030126971

64 

M L Agostini E L Andres A C Sims R L Graham T P Sheahan X Lu Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and theASM J202292115

65 

T P Sheahan A C Sims S R Leist A Schäfer J Won A J Brown Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNat Commun202011222114

66 

M L Holshue C Debolt S Lindquist K H Lofy J Wiesman H Bruce First case of 2019 novel coronavirus in the United StatesN Engl J Med20203821092936

67 

L Zhang Y Liu Potential interventions for novel coronavirus in china: a systematic reviewJ Med Virol202092547990

68 

P Richardson I Griffin C Tucker D Smith O Oechsle A Phelan Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseLancet202039510223e301

69 

V K Derebail R J Falk ANCA - Associated vasculitis refining therapy with plasma exchange and glucocorticoidsN Engl J Med202038276713

70 

X Tian C Li A Huang S Xia S Lu Z Shi Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerg Microbes Infect2020913825

71 

Y R Guo Q D Cao Z S Hong Y Y Tan S D Chen H J Jin The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the statusMil Med Res20207111

72 

J M Jenkins M S Campos J K Baillie The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysisJ Infect Dis201521118090

73 

K L Koenig Identify-Isolate-Inform: A modified tool for initial detection and management of Middle East Respiratory Syndrome patients in the emergency departmentWest J Emerg Med201516561924

74 

Y H Jin L Cai Z S Cheng H Cheng Deng Y P Fan A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)Mil Med Res202074123

75 

J Lei J Li X Li X Qi CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumoniaRadiol2020295118



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Editorial


Article page

90-97


Authors Details

A.G. Nerkar, Praneeta Pawale


Article History

Received : 20-05-2022

Accepted : 15-07-2022


Article Metrics


View Article As

 


Downlaod Files